GSMYX
Price
$23.94
Change
+$0.28 (+1.18%)
Updated
Jul 25 closing price
Net Assets
1.47B
PMAQX
Price
$48.54
Change
+$0.35 (+0.73%)
Updated
Jul 25 closing price
Net Assets
33.03B
Interact to see
Advertisement

GSMYX vs PMAQX

Header iconGSMYX vs PMAQX Comparison
Open Charts GSMYX vs PMAQXBanner chart's image
Goldman Sachs Small/Mid Cap Growth Instl
Price$23.94
Change+$0.28 (+1.18%)
VolumeN/A
Net Assets1.47B
Principal MidCap R6
Price$48.54
Change+$0.35 (+0.73%)
VolumeN/A
Net Assets33.03B
GSMYX vs PMAQX Comparison Chart in %
Loading...
View a ticker or compare two or three
VS
GSMYX vs. PMAQX commentary
Jul 27, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is GSMYX is a StrongBuy and PMAQX is a Buy.

Interact to see
Advertisement
FUNDAMENTALS
Fundamentals
PMAQX has more cash in the bank: 33B vs. GSMYX (1.47B). PMAQX pays higher dividends than GSMYX: PMAQX (0.19) vs GSMYX (0.00). GSMYX was incepted earlier than PMAQX: GSMYX (20 years) vs PMAQX (9 years). GSMYX (0.92) is less costly to investors than PMAQX (0.59). GSMYX is a more actively managed with annual turnover of: 69.00 vs. PMAQX (10.50). PMAQX has a lower initial minimum investment than GSMYX: PMAQX (0) vs GSMYX (1000000). PMAQX annual gain was more profitable for investors over the last year : 13.16 vs. GSMYX (1.23). PMAQX return over 5 years is better than : 57.67 vs. GSMYX (-2.21).
GSMYXPMAQXGSMYX / PMAQX
Total Expense Ratio0.920.59156%
Annual Report Gross Expense Ratio0.920.59156%
Fund Existence20 years9 years-
Gain YTD-2.6837.977-34%
Front LoadN/AN/A-
Min. Initial Investment10000000-
Min. Initial Investment IRAN/AN/A-
Net Assets1.47B33B4%
Annual Yield % from dividends0.000.19-
Returns for 1 year1.2313.169%
Returns for 3 years26.1349.7653%
Returns for 5 years-2.2157.67-4%
Returns for 10 years3.23N/A-
View a ticker or compare two or three
Interact to see
Advertisement
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
CHSCP27.720.17
+0.62%
CHS
NLOP33.420.19
+0.57%
Net Lease Office Properties
CLDX23.350.13
+0.56%
Celldex Therapeutics
MUR26.13-0.20
-0.76%
Murphy Oil Corp
IPSC0.63-0.03
-5.17%
Century Therapeutics